Search

Search Results

• PO061 | LONG-TERM HEADACHE IMPROVEMENT WITH VITAMIN K ANTAGONISTS IN PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME: 2-YEAR OBSERVATIONAL COHORT A. Hoxha^1|2, C. Belizna³, E. Esteve-Valverde⁴, A. Prundean⁵, A. Godon⁶, G. Gobbo^1|2, A. Anunciación-Llunell^7|8|9, R. Ferrer-Oliveras¹⁰, J.O. Latino¹¹, S. Udry¹¹, J. Alijotas-Reig^7|8|9 | ¹Department of Medicine, University of Padua, Padova, Italy; ²Internal Medicine Unit, Thrombosis and Bleeding Disorder Center, University Hospital of Padua, Padova, Italy; ³Vascular and Coagulation Department, University Hospital Angers, Angers, France; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵University of Angers, Inserm, CNRS, MITOVASC, SFR ICAT, Angers, France; ⁶Centre Hospitalier Universitaire Angers, Institut National de la Santé et de la Recherche Médicale, Centre National de la Recherche Scientifique, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Laboratoire d'Hématologie, Université d'Angers, Nantes Université, Angers, France; ⁷Department of Medicine, Universitat Autònoma de Barcelona, Spain; ⁸Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Spain; ⁹Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca, Barcelona, Spain; ¹⁰Obstetrics Department, High-Risk Unit, Hospital Universitario Quirónsalud, Barcelona, Spain; ¹¹Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.877

  0

  PDF: 0

• CO049 | RANDOMIZED CONTROLLED TRIAL TO IDENTIFY THE OPTIMAL SCHEME OF HEPARIN FOR TREATMENT OF DEEP VEIN THROMBOSIS IN PREGNANCY E. Grandone^1|3, E. Antonucci², A. de Laurenzo¹, L. Latino¹, M. Mastroianno¹, G. Tiscia¹, M. Margaglione³, P. Prandoni² | ¹IRCCS Casa Sollievo della Sofferenza, S.Giovanni Rotondo, Italy; ²Fondazione Arianna, Italy; ³Università di Foggia, Italy

  Elvira Grandone

  26-10-2026

  https://doi.org/10.4081/btvb.2026.751

  1

  PDF: 0

• CO097 | IMPACT OF THE 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CRITERIA IN 1200 WOMEN WITH PRIOR OBSTETRIC ANTIPHOSPHOLIPID SYNDROME J. Alijotas-Reig^1|2|3, E. Esteve-Valverde⁴, L. Saez-Comet⁵, A. Anunciacion-Llunell³, R. Ferrer-Oliveras⁶, E. Lefkou⁷, A. Mekinian⁸, C. Belizna⁹, A. Hoxha¹⁰, A. Tincani¹¹, L. Marozio¹², G. Espinosa¹³, S. de Carolis¹⁴, S. Udry¹⁵, J.O. Latino¹⁵, E. Llurba¹⁶, C.B. Chighizola^17|18, M. Gerosa¹⁹, V. Pengo²⁰, K. Lundelin²¹, P. Rovere-Querini²², V. Canti²², K. Mayer-Pickel²³, T. Reshetnyak²⁴, S. Tabacco²⁵, L. Stojanovich²⁶, B.A. Gonçalves²⁷, S. Morales-Perez¹, F. Miro-Mur³ | ¹Department of Medicine, Universitat Autonoma de Barcelona, Spain; ²Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Spain; ³Systemic Autoimmune Diseases Research Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain; ⁶Obstetrics Department, High-Risk Unit, Hospital Universitario Quironsalud, Barcelona, Spain; ⁷Haematology Unit, Hippokration Hospital of Thessaloniki, Greece; ⁸AP-HP, Hopital Saint-Antoine, Service de Medecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universites, Paris, France; ⁹Vascular and Coagulation Department, University Hospital Angers, Angers, France; ¹⁰Internal Medicine Unit, Thrombotic and Bleeding Disorder Center, University of Padua, Padova, Italy; ¹¹Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy; ¹²Department of Obstetrics and Gynaecology, Universita di Torino, Torino, Italy; ¹³Systemic Autoimmune Diseases Service, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; ¹⁴Department of Gynaecology, Gemelli Hospital, Catholic University, Roma, Italy; ¹⁵Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina; ¹⁶Obstetrics and Gynaecology Department, High-Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ¹⁷Department of Clinical Science and Community Health, University of Milano, Milano, Italy; ¹⁸Unit of Pediatric Rheumatology, ASST G. Pini-CTO, Milano, Italy; ¹⁹Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; ²⁰Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy; ²¹Department of Pediatrics, Faculty of Medicine, University of Turku, Turku, Finland; ²²Internal Medicine and Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; ²³Department of Obstetrics, Medical University of Graz, Graz, Austria; ²⁴Department of Systemic Rheumatic Disease, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia; ²⁵Department of Gynecology, Obstetrics and Urology, Sapienza University of Roma, Roma, Italy; ²⁶University Medical Center, University of Belgrade, Belgrade, Serbia; ²⁷Department of Internal Medicine, Hospital Sant Joan Despí Moises-Broggi, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.799

  0

  PDF: 0